Welcome to our dedicated page for Lucyd SEC filings (Ticker: LUCY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Innovative Eyewear, Inc. (NASDAQ: LUCY; LUCYW) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed information on corporate actions, governance decisions and other material events affecting the developer and manufacturer of ChatGPT-enabled smart eyewear under the Lucyd, Lucyd Armor, Reebok, Eddie Bauer and Nautica brands.
Through this page, readers can review current and historical filings such as Form 8-K reports describing significant events. For example, recent 8-K filings have covered matters submitted to stockholders at the annual meeting, including the approval of an amendment to change the company’s name from Innovative Eyewear, Inc. to Lucyd, Inc., as well as changes in officer titles and responsibilities within the finance and AI functions.
Investors can also use this page to locate annual reports on Form 10-K, quarterly reports on Form 10-Q and other filings that detail financial results, risk factors, business descriptions and segment information relevant to Innovative Eyewear’s smart eyewear operations. In addition, Form 4 insider transaction reports, when filed, provide transparency into purchases or sales of LUCY securities by directors and officers, including any open-market buying that management has stated will be disclosed through required SEC forms.
Stock Titan enhances these filings with AI-powered summaries that explain key points in accessible language, helping readers interpret complex sections of lengthy documents such as 10-Ks and 10-Qs. Real-time updates from the SEC’s EDGAR system ensure that new filings for LUCY appear promptly, while AI-generated highlights draw attention to notable changes in governance, capital structure or strategic direction.
By combining raw SEC documents with AI analysis, this page serves as a focused resource for understanding Innovative Eyewear’s regulatory history, corporate decisions and disclosed financial information.
Innovative Eyewear Inc. Chief Executive Officer and director Harrison R. Gross reported buying 1,500 shares of the company’s common stock on January 8, 2026 at a price of $1.60 per share. After this transaction, he beneficially owned 12,233 common shares in total, held directly. The filing notes that this trade created a short-swing profit under Section 16(b) of the Securities Exchange Act, and Gross voluntarily paid $629.45, the full amount of that profit, back to the company on January 11, 2026.
Innovative Eyewear Inc. reported an insider share purchase by its Chief AI & Growth Officer, Konrad Dabrowski. On 01/08/2026, he bought 1,300 shares of the company’s common stock at a price of $1.58 per share, increasing his direct beneficial ownership to 12,804 shares.
The accompanying note states that this transaction resulted in a short-swing profit under Section 16(b) of the Securities Exchange Act of 1934. Dabrowski agreed to voluntarily disgorge $551.35, described as the full amount of that profit, to the issuer, and this amount was paid in full on January 12, 2026.
Innovative Eyewear Inc. major shareholders Vladimir and Angelica Galkin have fully exited their position. In this Amendment No. 10 to Schedule 13D, they report selling 647,505 shares of common stock, which represented approximately 12.1% of Innovative Eyewear’s outstanding shares, through open market transactions completed effective January 7, 2026.
After these sales, each of the reporting persons beneficially owns 0 shares, or about 0.0% of the company’s common stock, based on 5,350,183 shares outstanding as of November 6, 2025. They state that they no longer believe Innovative Eyewear represents an attractive investment given its business prospects and strategy, and they report no additional plans regarding corporate actions.
Innovative Eyewear Inc. 10% owner Vladimir Galkin reported recent trades in the company’s common stock. On January 2, 2026, he reported purchasing 4,000 shares of common stock at a volume‑weighted average price of $1.02 per share, bringing reported beneficial ownership to 643,505 shares.
On January 7, 2026, he reported an additional transaction of 643,505 shares at a volume‑weighted average price of $1.79 per share, after which the table shows 0 shares beneficially owned. The filing notes that these shares are held jointly by Vladimir and Angelica Galkin as husband and wife, and that prices are volume‑weighted averages that include commissions.
Innovative Eyewear, Inc. filed a current report to disclose that it issued a press release with preliminary financial results and operational highlights for its 2025 fiscal year. The company states that the press release, dated January 7, 2026, is included as Exhibit 99.1 to this report and is furnished under Items 2.02 and 7.01 of the Exchange Act.
The company clarifies that this information is being furnished rather than filed, meaning it is not subject to certain liability provisions of the Exchange Act and will only be incorporated into other securities filings if specifically referenced.
Innovative Eyewear Inc. director and 10% owner Vladimir Galkin reported multiple transactions in the company’s common stock. On 12/29/2025, he reported a transaction in 46,107 shares at a price of $1.10 per share, leaving 749,900 shares beneficially owned. On 12/30/2025, he reported 11,303 shares at $1.08 per share, with 738,597 shares beneficially owned afterward. On 12/31/2025, he reported 89,830 shares at $0.99 per share, leaving 648,767 shares beneficially owned. On 01/02/2026, he reported 1,262 shares at $0.97 per share, for a resulting beneficial ownership of 647,505 shares. The filing notes that the reported per share prices include commissions and that the shares are held jointly by Vladimir and Angelica Galkin.
Innovative Eyewear Inc director Vladimir Galkin reported two transactions in the company’s common stock. On 12/10/2025, a transaction labeled code 'P' involved 50,300 shares at $1.49 per share, leaving 947,193 shares beneficially owned directly afterward. On 12/11/2025, another code 'P' transaction covered 8,423 shares at $1.58 per share, with 938,770 shares beneficially owned directly afterward. The filing notes these common shares are held jointly by Vladimir and Angelica Galkin, husband and wife.
Innovative Eyewear Inc reported an insider stock purchase by director Vladimir Galkin. On 12/04/2025, he bought 2,507 shares of common stock at $1.5 per share in an open-market transaction classified as a purchase.
After this trade, Galkin beneficially owns 997,493 shares of Innovative Eyewear common stock. The filing explains that these shares are held jointly by Vladimir Galkin and his wife, Angelica Galkin, reflecting shared ownership within the household.
Innovative Eyewear (LUCY) filed its Q3 2025 10‑Q reporting stronger sales and improved margins. Revenue for the quarter was $668,128, up sharply from $253,599 a year ago, driven by the Lucyd Armor safety line and the Reebok Powered by Lucyd collection. Gross profit rose to $244,837, with gross margin improving to 37% from 23% as sourcing and logistics efficiencies offset tariff pressures. The company reported a net loss of $(1,836,267) versus $(1,720,677) in the prior-year quarter.
Year-to-date revenue reached $1,701,859, with a net loss of $(5,721,064). Cash and cash equivalents were $6,699,515 as of September 30, 2025, supported by cash inflows from warrant exercises, inducement transactions, and at‑the‑market sales. Stockholders’ equity increased to $10,250,218. Management states liquidity is expected to fund operations for at least the next 12 months. A subsequent event adds $570,000 from a legal settlement. As of November 6, 2025, there were 5,350,183 common shares outstanding.
Innovative Eyewear (LUCY) announced executive title changes. Konrad Dabrowski resigned as Co‑Chief Financial Officer and became Chief AI and Growth Officer. Oswald Gayle, previously Co‑Chief Financial Officer, is now Chief Financial Officer and will serve as the company’s principal financial officer.
The Board of Directors approved these changes effective November 1, 2025. The company stated there were no compensation changes for Mr. Dabrowski or Mr. Gayle in connection with the new roles.